日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

China unveils rules for 11th round of natl centralized drug procurement

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2025-09-21 14:02
Share
Share - WeChat
Pharmacists dispense drugs at a hospital in Huzhou, Zhejiang province, in August. [Photo by Yi Fan/For China Daily]

The National Healthcare Security Administration on Saturday released the rules for the 11th round of its national drug centralized procurement program, focusing on ensuring clinical supply, guaranteeing drug quality and countering market involution.

Launched in 2018, the national bulk-buy program aims to reduce the financial burden on patients by having pharmaceutical manufacturers participate in a competitive bidding process, lowering prices and securing large-volume contracts with major public hospitals.

To better align with clinical needs, the administration said during the latest round, medical institutions can report their procurement requirements either by generic drug name — as was previously the practice — or by specifying preferred brands.

If a hospital's preferred brand wins the bid, the corresponding manufacturer will supply the product directly to that institution.

About 46,000 medical institutions participated in this round of demand reporting, with 77 percent specifying brands, the administration said.

In addition, the administration has adjusted pricing comparison rules for small-volume pediatric drugs to encourage the supply of low-dosage medications tailored for children.

To further ensure the quality of selected drugs, higher standards will be applied to the quality control capabilities of bidding enterprises, with priority given to manufacturers with broad clinical recognition and consistent quality records.

The administration stressed maintaining an open, transparent, fair and market-oriented competition mechanism and "taking a firm stance against excessive involution".

Companies are required to submit bids no lower than their production costs, and any bid below a preestablished anchor price — determined by experts and regulatory authorities — must be justified to address public concerns over abnormally low-priced bids.

The past ten rounds of the national centralized drug procurement program have covered 435 types of medicines, achieving an average price cut of 50 percent.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 久久久久久蜜桃 | 亚洲精品久 | 久久性av | 婷婷久久五月天 | 欧日韩不卡视频 | 一及黄色片 | 午夜视频一区二区 | 中文字幕在线观看你懂的 | 色综合精品 | 91最新在线视频 | 影音先锋男人天堂 | 成长的秘密在线观看 | 国产三级在线观看 | 欧美另类在线观看 | 在线观看av中文字幕 | 丁香在线视频 | 5060网午夜 | 亚洲黄色精品 | 老牛影视av一区二区在线观看 | 欧美日韩色视频 | 天天干天天干天天干天天 | 婷婷影音| 一本毛片 | 色视频免费看 | 激情五月色播五月 | 自拍三级| 久久77| 成人18视频免费69 | 激情高潮到大叫狂喷水 | 国产日韩欧美另类 | 一区在线播放 | 在线观看成人 | 亚洲第一色网站 | 欧美二三区 | 成年人在线观看网站 | 中文字幕一区不卡 | 国产激情图片 | 午夜视频精品 | 一级片久久久 | 香蕉成人网| 中国成人毛片 |